Concentrix Corporation
CNXC
$51.26
$1.052.09%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.37B | 2.45B | 2.39B | 2.38B | 2.40B |
| Total Other Revenue | -- | -- | -- | -- | 582.68M |
| Total Revenue | 2.37B | 2.45B | 2.39B | 2.38B | 2.40B |
| Cost of Revenue | 1.52B | 1.58B | 1.52B | 1.52B | 1.55B |
| Gross Profit | 855.90M | 870.60M | 864.19M | 857.57M | 856.53M |
| SG&A Expenses | 667.44M | 215.11M | 674.31M | 676.40M | 678.04M |
| Depreciation & Amortization | -- | 458.93M | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.18B | 2.25B | 2.20B | 2.20B | 2.22B |
| Operating Income | 188.46M | 196.56M | 189.88M | 181.17M | 178.49M |
| Income Before Tax | 100.79M | 112.91M | 26.42M | 87.13M | 72.82M |
| Income Tax Expenses | 30.54M | -2.74M | 9.79M | 20.29M | 20.72M |
| Earnings from Continuing Operations | 70.26M | 115.65M | 16.63M | 66.83M | 52.10M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 70.26M | 115.65M | 16.63M | 66.83M | 52.10M |
| EBIT | 188.46M | 196.56M | 189.88M | 181.17M | 178.49M |
| EBITDA | 349.17M | 365.28M | 366.00M | 358.11M | 362.55M |
| EPS Basic | 1.04 | 1.73 | 0.25 | 0.98 | 0.76 |
| Normalized Basic EPS | 1.14 | 1.50 | 0.71 | 1.07 | 0.84 |
| EPS Diluted | 1.04 | 1.73 | 0.25 | 0.98 | 0.76 |
| Normalized Diluted EPS | 1.14 | 1.50 | 0.70 | 1.07 | 0.84 |
| Average Basic Shares Outstanding | 64.04M | 64.32M | 64.66M | 65.27M | 65.66M |
| Average Diluted Shares Outstanding | 64.07M | 64.35M | 64.75M | 65.33M | 65.79M |
| Dividend Per Share | 0.33 | 0.33 | 0.30 | 0.30 | 0.30 |
| Payout Ratio | 31.86% | 19.57% | 121.54% | 30.44% | 39.56% |